Saudi Arabia - Healthcare (Pharmaceuticals and Medical Devices), Regulatory and Reimbursement Landscape
Description
Saudi Arabia - Healthcare (Pharmaceuticals and Medical Devices), Regulatory and Reimbursement Landscape
Summary
GlobalData, the industry analysis specialist, has released its latest report “Saudi Arabia - Healthcare (Pharmaceuticals and Medical Devices), Regulatory and Reimbursement Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Saudi Arabia. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
Saudi Arabia’s pharmaceutical market has high potential and is one of the fastest developing pharmaceutical markets in Asia. The rise in communicable and non-communicable diseases, and government initiatives such as National Drug Policy intended to drive the growth of the Saudi Arabia’s pharmaceutical market. While inadequate power and water supply, dysfunctional transport system, and under-utilized manufacturing capacity, along with counterfeiting drugs are hindering the development of the healthcare market. Saudi Arabia’s pharmaceutical market, based on pharmaceutical production value, $6.6 billion in 2013 is expected to increase to $10.2 billion in 2020 at a Compound Annual Growth Rate (CAGR) of 6.4%. It is forecast to reach about $14.8 billion in 2026. The medical devices market of Saudi Arabia was valued at $3.6 billion in 2016, which is expected to increase to $4.8 billion in 2020 at a CAGR of 6.0%. The medical device market is expected to grow at a CAGR of 4% from $5 billion in 2021 to $6.1 billion in 2027.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Saudi Arabia, and includes -
This report will enhance your decision-making capability by allowing you to -
Summary
GlobalData, the industry analysis specialist, has released its latest report “Saudi Arabia - Healthcare (Pharmaceuticals and Medical Devices), Regulatory and Reimbursement Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Saudi Arabia. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
Saudi Arabia’s pharmaceutical market has high potential and is one of the fastest developing pharmaceutical markets in Asia. The rise in communicable and non-communicable diseases, and government initiatives such as National Drug Policy intended to drive the growth of the Saudi Arabia’s pharmaceutical market. While inadequate power and water supply, dysfunctional transport system, and under-utilized manufacturing capacity, along with counterfeiting drugs are hindering the development of the healthcare market. Saudi Arabia’s pharmaceutical market, based on pharmaceutical production value, $6.6 billion in 2013 is expected to increase to $10.2 billion in 2020 at a Compound Annual Growth Rate (CAGR) of 6.4%. It is forecast to reach about $14.8 billion in 2026. The medical devices market of Saudi Arabia was valued at $3.6 billion in 2016, which is expected to increase to $4.8 billion in 2020 at a CAGR of 6.0%. The medical device market is expected to grow at a CAGR of 4% from $5 billion in 2021 to $6.1 billion in 2027.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Saudi Arabia, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Novartis, GlaxoSmithKline, Pfizer, Tabuk, and SPIMACO.
- Profiles and SWOT analyses of the major players in the medical device market: Fujitsu, Medtronic, AstraZeneca, Kimberly Clark and GE Healthcare.
- An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure.
- An overview of the opportunities for and challenges to growth in the Saudi Arabian healthcare market.
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Saudi Arabian healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Saudi Arabian healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
Table of Contents
171 Pages
- Key Highlights: Facts About the Saudi Arabia Healthcare Market
- Key Highlights: Healthcare Startups in Saudi Arabia
- Key Events: Saudi Arabia Pharmaceutical News, 2015-2021
- Key Events: Saudi Arabia Pharmaceutical Market
- Key Events: M&As, VF, and PE Deals, Global Pharmaceutical Market, 2020-2021
- Key Events: Top Completed Deals by Value, 2020-2021
- Country Profile, Saudi Arabia, 2022
- Pharmaceutical Market - Overview
- Pharmaceutical Market - Exports
- Pharmaceutical Market - Imports
- Pharmaceutical Market - Supply Channels, Saudi Arabia
- Pharmaceutical Market - Market Segments
- Pharmaceutical Market - Market Segment, Generic Drugs, Saudi Arabia
- Pharmaceutical Market - Market Segment, Biosimilars, Saudi Arabia
- Pharmaceutical Market - Market Segment, Biologics, Saudi Arabia
- Pharmaceutical Market - Market Segment, Biologics and Biosimilars, Saudi Arabia
- Pharmaceutical Market - Market Segment, Over-the-Counter Medicines, Saudi Arabia
- COVID-19 Epidemiology, Saudi Arabia
- COVID-19 Impact and Developments, Saudi Arabia
- COVID-19 Impact and Developments in the Healthcare Market, Saudi Arabia
- COVID-19 Clinical Trials Landscape, Saudi Arabia
- Pharmaceutical Market - Major Players
- Medical Devices Market - Overview
- Medical Devices Market - Major Segments
- Medical Devices Market - Hospital Supplies and General Surgery Market
- Medical Devices Market - Orthopedic Devices and Cardiovascular Devices Market
- Medical Devices Market - Anesthesia and Respiratory Devices Market
- Medical Devices Market - Diagnostic Market
- Medical Devices Market - Major Players
- Drivers and Barriers
- Deal Analysis: Pharmaceutical Market, Saudi Arabia, 2019-2022
- Deal Analysis: Medical Devices Market, Saudi Arabia, 2019-2022
- HealthTech Landscape, Saudi Arabia
- HealthTech Deals Landscape, Saudi Arabia
- Key HealthTech Deals, Saudi Arabia
- Adoption of Technology in Healthcare, Saudi Arabia
- Digital Statistics, Saudi Arabia
- Digital Health Regulations, Saudi Arabia
- Digital Health - Benefits and Risks, Saudi Arabia
- Overview of Healthcare System, Saudi Arabia
- Reimbursement of Drugs, Saudi Arabia
- Reimbursement Process, Saudi Arabia
- Overview of Insurance Providers, Saudi Arabia
- Out-of-Pocket Spending and Pharmaceutical Price Index, Saudi Arabia
- Pricing Policies, Saudi Arabia
- Overview of Regulatory Agencies, Saudi Arabia
- Marketing Authorization for Pharmaceutical Products, Saudi Arabia
- Market Authorization for Medical Devices, Saudi Arabia
- Marketing Authorization for Biosimilars and Biologics, Saudi Arabia
- Pharmaceutical Exports and Imports, Saudi Arabia
- Intellectual Property Rights, Patents, Saudi Arabia
- Intellectual Property Rights, Trademarks, Saudi Arabia
- Clinical Trial Regulations, Saudi Arabia
- Pharmaceutical Clinical Trials Landscape, Saudi Arabia
- Medical Devices Clinical Trials Landscape, Saudi Arabia
- Pharmacy License Regulations, Saudi Arabia
- Pharmaceutical Advertising Regulations, Saudi Arabia
- Labeling and Packaging Regulations, Saudi Arabia
- Saudi Arabia Healthcare Policy Highlights
- Healthcare Facilities, Saudi Arabia
- Healthcare Parameters, Saudi Arabia
- Life Expectancy and Immunization Rate, Saudi Arabia
- Environmental Health, Saudi Arabia
- Healthcare Personnel, Saudi Arabia
- Disease Burden, Saudi Arabia
- Healthcare Expenditure, Saudi Arabia
- Trade Associations, Saudi Arabia
- Trade Fairs, Saudi Arabia
- Opportunities and Challenges
- Research Methodology
- Bibliography
- About GlobalData
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
